ARQT

NASDAQ 已收盘

Arcutis Biotherapeutics

27.17 USD
▼-0.44-1.59%
盘后 27.15 -0.07%
2026-11-19
市值
$3.33B
市盈率
121.54
EPS
0.22
股息率
—
52 周区间
19.30 – 34.80
成交量
1.33M
Beta
1.63
目标价
40.38
52W 低 19.3052W 高 34.80
价格走势

公司简介

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company’s lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist of the CD200 receptor. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Bio...